Mark Cuban Cost Plus Drug Company, PBC Joins Forces with Seva-Rx to Expand Transparent, Affordable Prescription Access
June 30, 2025 – Dallas, TX & Crown Point, IN The Mark Cuban Cost Plus Drug Company, PBC (“Cost Plus Drugs”) announced today a new joint venture with Seva-Rx, a forward-thinking Pharmacy Benefit Manager (PBM) committed to transparency and innovation in prescription drug access.
Read more
